Navigation Links
Parkinson's Drugs Tied to Compulsive Behaviors
Date:5/10/2010

e other populations are needed to examine the possible relationships between dopamine agonist treatment, other clinical features and impulse control disorders," the authors concluded.

The study is published in the May issue of the journal Archives of Neurology.

More information

The Parkinson's Disease Foundation has more about Parkinson's disease patients and impulse control problems.



-- Robert Preidt



SOURCE: JAMA/Archives journals, news release, May 10, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Stomach Acid Drugs Come with Dangers, Studies Show
2. Anemia Drugs Hold Dangers for Kidney Patients
3. As FDA Eyes Prostate Cancer Drugs, Experts Urge Caution
4. Taking Flu Drugs While Pregnant Appears to Be Safe: Study
5. OTC Drugs May Work Differently in Obese Kids
6. Study finds that drugs used for treatment of influenza in pregnancy appear to be safe
7. BATTLE links potential biomarkers to drugs for lung cancer
8. Matching Tumor Types to Drugs Boosts Lung Cancer Outcomes
9. Cholesterol Drugs May Slow MS
10. Real Men Don't Take Erectile Dysfunction Drugs Without a Prescription
11. Poisoning by prescription drugs on the rise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... ... June 29, 2015 , ... The Mesothelioma Applied Research Foundation ... support program. This discussion series is part of the Meso Foundation’s larger program ... affected by mesothelioma. , The six week discussion series is tailored to mesothelioma ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... the weekend edition of USA TODAY. This 12-page, glossy, full-color special section hit ... in highly targeted markets totaling approximately 450,000 copies, with an estimated readership of ...
(Date:6/29/2015)... ... June 29, 2015 , ... Lake ... Balboa Care Center”, showcasing its prestigious five-star, premium rating from Medicare. Medicare’s ratings ... Balboa views this rating as indicative of its commitment to providing patients with ...
(Date:6/29/2015)... ... June 29, 2015 , ... A state-of-the-art ... NewYork-Presbyterian/Weill Cornell Medical Center. The device is the first of its kind approved ... positive airway pressure (CPAP), the current standard of care for OSA. , Some ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... announces the Fresh Plus Diaper, a baby invention that makes parenthood less tiring ... projected to reach a market value of USD 52.2 billion in 2017," says ...
Breaking Medicine News(10 mins):Health News:Mesothelioma Organization Provides Support for Patients and Families 2Health News:Mesothelioma Organization Provides Support for Patients and Families 3Health News:Mediaplanet partners with USA TODAY and Kris Letang to raise awareness about the risk of heart attack and stroke 2Health News:Lake Balboa Releases New Facility Video of Patient Testimonials 2Health News:NewYork-Presbyterian/Weill Cornell Medical Center Is First in New York to Offer New Alternative Treatment for Sleep Apnea 2Health News:NewYork-Presbyterian/Weill Cornell Medical Center Is First in New York to Offer New Alternative Treatment for Sleep Apnea 3Health News:NewYork-Presbyterian/Weill Cornell Medical Center Is First in New York to Offer New Alternative Treatment for Sleep Apnea 4Health News:Bringing Up Baby...Millenials Should Check World Patent Marketing's New Baby Invention 2Health News:Bringing Up Baby...Millenials Should Check World Patent Marketing's New Baby Invention 3Health News:Bringing Up Baby...Millenials Should Check World Patent Marketing's New Baby Invention 4Health News:Bringing Up Baby...Millenials Should Check World Patent Marketing's New Baby Invention 5
... of older Americans and certain ethnic groups will have ... thought, according to the latest issue of Public ... Baby Boomer generation and residents of Hispanic and Asian ... swell. , The entire issue is authored by cutting-edge ...
... Week and supports the ... for Women,s Health Research, NORTHRIDGE, Calif., April 23 American ... on,May 15, 2008 in honor of National Women,s Health Week. The ... of liquid softgels,formulated for easy absorption and easy to swallow, in ...
... Examines Reconstruction Innovations for Breast Cancer,Patients Including Partial ... 23 Lumpectomy,or breast conservation surgery is the ... A benefit of the surgery is that only ... can be the resulting physical,appearance of the breast, ...
... Dr. Vinton G. Cerf, Vice President and,Chief Internet ... Kahn,Chairman, CEO & President, Corporation for National Research ... of network,architecture and communication protocol for the Internet. ... the McKusick-Nathans,Institute of Genetic Medicine at The Johns ...
... affects most of the elder men and often compresses ... Idzenga has found a way to measure the resistance ... behind the scrotum. The sound spectrum of the recorded ... compressed. , Elder men with voiding symptoms, such ...
... LAUDERDALE, Fla., April 23 LifeSync Corporation, ... announced it has entered,into a non-exclusive sublicense ... associated with the digital, wireless communication of,patient ... Triage Wireless the right to utilize,LifeSync,s technologies ...
Cached Medicine News:Health News:Nature Made(R) Liquid Softgels Presents American Idol's Kimberley Locke Live in Concert 2Health News:Nature Made(R) Liquid Softgels Presents American Idol's Kimberley Locke Live in Concert 3Health News:Nature Made(R) Liquid Softgels Presents American Idol's Kimberley Locke Live in Concert 4Health News:Breast Reconstruction Advances Fix Distortions Left by Lumpectomy 2Health News:Breast Reconstruction Advances Fix Distortions Left by Lumpectomy 3
(Date:6/29/2015)... , June 29, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ... added to the Russell 1000 Index, effective June 26, ... the large-cap segment of the U.S. equity universe. It ... includes approximately 1000 of the largest securities based on ... membership. "We are pleased to be added ...
(Date:6/29/2015)... Axxess , an industry leader in ... vendor accredited by the American Nursing Credentialing Center – ... agencies select the right revenue cycle management (RCM) system ... business. Research by American Health Information Management ... a decrease in productivity of 54.4 - 69 percent ...
(Date:6/29/2015)... 29, 2015  Arbor Solution has added another ... high-powered, multi-functional M2150 offers two platforms: ... Core i5-4402E 1.6 GHz processor and i5-4422E ... and computing performance. Integrated Intel® HD Graphics 4600 ... suited for graphics-intense applications in operating rooms, clinical ...
Breaking Medicine Technology:ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 2ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 3Axxess Releases eGuide for Home Health Agencies, Revenue Cycle Management: What You Must Do Now - to Succeed! 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 3
... N.J., July 05, 2007 /PRNewswire/ -- Results ... open-label, Phase,3 study showed that 77 percent ... 600 mg tablets with,100 mg ritonavir (PREZISTA/r) ... of antiretroviral (ARV) agents, reached a,plasma viral ...
... 2007 - ZIOPHARM,Oncology, Inc. (NASDAQ: ZIOP) announces ... II trial of ZIO-201 (isophosphoramide mustard,- IPM) ... at the,European Society of Medical Oncology (ESMO) ... The abstract entitled, "Phase-I/II,Study of IPM (ZIO-201) ...
Cached Medicine Technology:New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 2New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 3New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 4New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 5New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 6New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 7New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 8Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 2Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 3
Nordan tying forceps, straight, titanium, 6.5 mm tying platforms....
Harms-Tuebingen tying forceps, straight, 6 mm tying platforms....
Castroviejo straight tying forceps, straight shafts, 5 mm tying platforms, wide handle....
Shepard tying forceps, round curved platform 8 mm, 8.5 cm....
Medicine Products: